18/06/2013 17:57:05 Free Membership Login
Alliance Pharma
   

Alliance Pharma Company Financial Information
Alliance Pharma share price | Alliance Pharma company information | Alliance Pharma Share Charts | Alliance Pharma Share News
 Company name: Alliance Pharma
 EPIC: APH Trading Currency: GBX
 Market Sector: AIM ISIN: GB0031030819
 Market Segment: AIM Share Type: DE
 WWW Address:  Description: ORD 1P
 Industry Sector: PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Ask Open High Low Volume
 36.38 mages.advfn.com/imagesnew/2/us/dot 0.0 [0.00] 36.00 36.75 36.38 36.38 36.38 129,075
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 90.95 250.02 0.30 3.61 0.83 10.08 2.28 39.50 - 21.50

Alliance Pharma Key Figures

(at previous day's close)
Market Cap.90.95m
Shares In Issue250.02m
Prev. Close36.38
PE Ratio10.08 
Dividend Yield2.28%
EPS - basic3.61p
Dividend PS0.83p
Dividend Cover4.35 
Cash Flow PS4.97p
Return On Equity (ROE)16.76%
Operating Margin24.08%
PEG Factor-36.48 
EPS Growth Rate-0.28%
Dividends PS Growth Rate10.67%
Net Debt44.14m
Gross Gearing48.47%
Quick Assets14.78m
Net Working Capital-1.87m
Intangibles / Fixed Assets99.30%
Turnover PS17.96p
Pre-Tax Profit PS4.32p
Retained Profit PS2.75p
Cash PS1.85p
Net Cash PS-6.96p
Net Tangible Asset Value PS *-11.22p
Net Asset Value PS20.74p
Spread0.75 (2.04%) 
* Calculation based on Ordinary Capital figure as contained in last annual report, and the most recent shares in issue figure. Therefore the ratio might be exposed to inaccuracies.

Alliance Pharma Balance Sheet

LSE:APH:Liabilities+EQLSE:APH:Assets

Alliance Pharma Share Price

Sample Period †HighLow
1 week37.1336.38
4 weeks37.6336.38
12 weeks39.5035.38
1 year39.5021.50

Alliance Pharma Share Price (5 years)

Alliance Pharma Historic Returns

Giorni da oggi †OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week37.13-0.75-2.0236.530.2636.50
4 weeks36.75-0.38-1.0236.630.2636.73
12 weeks35.880.501.3936.440.2636.58
26 weeks30.885.5017.8134.410.2334.94
1 year27.758.6331.0831.100.2231.27
3 years31.255.1316.4031.510.3432.15
5 years6.7529.63438.8925.080.3525.71
† periods calculated are whole weeks rather than calendar months

Alliance Pharma Key Management Ratios

Alliance Pharma Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio46.44 
PE Ratio10.08 
Tobin's Q Ratio 0.99 
Tobin's Q Ratio (excl. intangibles)4.93 
Dividend Yield2.28%
Market-to-Book Ratio1.75 
Price-to-Pre-Tax Profit PS8.41 
Price-to-Retained Profit PS13.21 
Price-to-Cash Flow PS7.31 
Price-to-Sales PS2.03 
Price-to-Net Tangible Asset Value PS-3.24 
Price-to-Cash PS19.63 
Net Working Capital PS-0.75 
Price Pct to Working Capital PS-48.56%
Earnings Yield9.92%
Average PE7.62 
Years in average5 
PE to PE average132.21%

Alliance Pharma Financial Ratios

(Leverage Ratios)
Debt Ratio34.02%
Debt-to-Equity Ratio0.52 
Debt-to-Equity Ratio (excl. Intgbl)-0.95 
Debt-to-Equity Market Value0.29 
Net Gearing43.87%
Net Gearing (excl. Intangibles)212.89%
Gross Gearing48.47%
Gross Gearing (excl. Intangibles)235.23%
Gearing Under 1 Year21.91%
Gearing Under 1 Year (excl. Intgbl)106.31%
Assets/Equity1.94 
Cash/Equity8.94 
(Liquidity Ratios)
Net Working Capital to Total Assets-1.86%
Current Ratio0.92 
Quick Ratio (Acid Test)0.67 
Liquidity Ratio0.21 
Cash & Equiv/Current Assets22.97%
(Solvency Ratios)
Enterprise Value113.05m
CFO/Sales0.28 
CFO/Attributable Profit1.43 
CFO/Assets0.12 
CFO/Debt0.25 
Total Debt/Equity Market Value0.54 
Total Debt/Sales1.09 
Total Debt/Pre-Tax Profit4.51 
Total Debt48.78m
Total Debt/Net Current Assets-26.04%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-%
5 yr Compound Earnings Growth18.42%
10 yr Compound Earnings Growth-%
Earn drops > 5% in 10yrs4 
Beta (60-Mnth)Beta (36-Mnth)
0.2975-0.1128
Alpha (60-Mnth)Alpha (36-Mnth)
0.04180.0081

Alliance Pharma Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)13.76%
Return On Assets (ROA)9.50%
Net Profit Margin19.36%
Assets Turnover0.49 
Return On Equity (ROE)16.76%
Return On Investment (ROI)11.82%
Dividend Payout Ratio22.99%
Plowback Ratio77.01%
Growth from Plowback Ratio13.95%
Net Income Of Revenues15.34%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.94 
Fixed Assets Turnover0.61 
Current Assets Turnover2.52 
Net Working Capital Turnover 
Inventory Turnover8.13 
(Other Operating Ratios)
Total Assets-to-Sales2.04 
Debtors-to-Sales20.94%
Debt Collection Period76.44Days

Alliance Pharma Dividends

Announcement DateTypeCurr.Dividend AmountPeriod StartPeriod EndEx DateRecord DatePayment DateTotal Dividend Amount
21 Mar 2013FinalGBX0.5512/31/201112/31/201206/12/201306/14/201307/11/20130.83
12 Sep 2012InterimGBX0.2812/31/201112/31/201212/05/201212/07/201201/15/2013-
22 Mar 2012FinalGBX0.5012/31/201012/31/201106/13/201206/15/201207/12/20120.75
07 Sep 2011InterimGBX0.2512/31/201012/31/201111/30/201112/02/201101/13/2012-
23 Mar 2011FinalGBX0.4012/31/200912/31/201006/15/201106/17/201107/14/20110.57
08 Sep 2010InterimGBX0.1712/31/200912/31/201012/01/201012/03/201001/14/2011-
24 Mar 2010FinalGBX0.2312/31/200812/31/200906/16/201006/18/201007/15/20100.30
09 Sep 2009InterimGBX0.0712/30/200806/30/200912/02/200912/04/200901/15/2010-

Alliance Pharma Fundamentals
 31 Dec 2009 (GBP)31 Dec 2010 (GBP)31 Dec 2011 (GBP)31 Dec 2012 (GBP)
turnover31.24100.00%49.88100.00%45.96100.00%44.90100.00%m
pre tax profit5.7418.38%12.8725.81%10.7123.31%10.8124.08%m
attributable profit4.1113.15%8.9517.95%8.6418.79%8.6919.36%m
retained profit4.1113.15%8.2916.61%7.2815.83%6.8915.34%m
eps - basic2.37 3.96 3.62 3.61 
eps - diluted2.14 3.64 3.39 3.40 
dividends per share0.30 0.57 0.75 0.83 

Alliance Pharma Balance Sheet

 31 Dec 2009 (GBP)31 Dec 2010 (GBP)31 Dec 2011 (GBP)31 Dec 2012 (GBP)
LSE:APH:Liabilities+EQLSE:APH:AssetsLSE:APH:Liabilities+EQLSE:APH:AssetsLSE:APH:Liabilities+EQLSE:APH:AssetsLSE:APH:Liabilities+EQLSE:APH:Assets
 31 Dec 2009 (GBP)31 Dec 2010 (GBP)31 Dec 2011 (GBP)31 Dec 2012 (GBP)
ASSETS
fixed assets fixed assets0.130.23%0.891.15%0.770.93%0.560.56%m
intangibles intangibles44.9479.11%60.2977.89%66.1380.37%79.8979.39%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks2.975.23%4.545.87%5.656.87%5.395.36%m
debtors debtors7.6613.48%9.6912.52%8.6610.52%10.1510.08%m
cash & securities cash & securities1.101.94%1.992.57%1.081.31%4.634.61%m
TOTAL56.80100%77.40100%82.29100%100.63100%m
LIABILITIES
creditors - short creditors - short11.4520.15%16.9821.94%13.8616.84%22.0521.91%m
creditors - long creditors - long28.7250.57%24.3431.45%24.3029.53%26.7326.57%m
creditors - other creditors - other--%--%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL40.1770.72%41.3253.38%38.1646.37%48.7848.47%m
EQUITY
ord cap, reserves ord cap, reserves16.6329.28%36.0846.62%44.1353.63%51.8551.53%m
prefs, minorities prefs, minorities--%--%--%--%m
TOTAL16.6329.28%36.0846.62%44.1353.63%51.8551.53%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Alliance Pharma Cash Flow Statement

31 Dec 2009 (GBP)31 Dec 2010 (GBP)31 Dec 2011 (GBP)31 Dec 2012 (GBP)
Operating CF10.3916.8110.1612.44m
Pre-Financing CF2.461.601.32-0.56m
Retained CF2.891.60-0.883.53m

Alliance Pharma Brokers

NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MMF)Broker/DealerEVOEVBGGB21MMT
Numis Securities LimitedMarket Maker(MMF)Broker/DealerNUMSRAZHGB2LBIC
Shore Capital Stockbrokers LtdMarket Maker(MMF)Broker/DealerSCAPSHOCGB21
Winterflood Securities LtdMarket Maker(MMF)Broker/DealerWINSWNTSGB2LBIC



NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's

1 site:2 us lse aph130618 17:57